Canaccord Genuity has downgraded Pliant (PLRX) to hold following news that the company has paused a clinical trial for its ...

VANCOUVER - Canaccord Genuity Group Inc. has crossed the threshold of a 10% ownership stake in Beeks Financial Cloud Group ...

Fintel reports that on February 10, 2025, Canaccord Genuity downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX) ...

Canaccord Genuity analyst Susan Anderson maintained a Buy rating on Edgewell Personal Care (EPC – Research Report) yesterday and set a price ...

Canaccord Genuity analyst Mark Photiades reiterated a Buy rating on Dunelm Group (DNLM – Research Report) today and set a price target of ...

Analysts at Canaccord Genuity slightly raised their target price on Celtic from 202.0p to 208.0p on Tuesday, stating the firm ...

Canaccord Genuity Group Inc. reported a net loss of $11.6 million for its fiscal third quarter, despite record revenue ...

Canaccord Genuity Group restated their buy rating on shares of BILL (NYSE:BILL – Free Report) in a research note issued to investors on Friday morning,Benzinga reports. Canaccord Genuity Group ...

Uncertainty around North American trade has hindered capital-markets activity and stalled investments in Canada, according to ...

A big dividend yield for a few years doesn't mean much if it can't be sustained. While Canaccord Genuity Group is not profitable, it is paying out less than 75% of its free cash flow, which means that ...

Illumina (NASDAQ:ILMN – Free Report) had its price objective cut by Canaccord Genuity Group from $145.00 to $135.00 in a report published on Friday,Benzinga reports. They currently have a hold rating ...

Canaccord Genuity Group Inc (TSX:CF) is set to release its Q3 2025 earnings on Feb 4, 2025. The consensus estimate for Q3 ...